Thursday 26 April 2018

Bioheart to open 2 ME cell therapy centres

Bioheart has planned to establish two centres of excellence in the region, to provide its cell therapy procedures to patients of congestive heart failure (CHF) and peripheral arterial disease (PAD). 'We feel that the Middle East region


US firm to test new heart treatment in Jordan

Mideast-backed US-based Bioheart will conduct a ground-breaking clinical trial on patients with congestive heart failure with a genetically-modified process in Jordan Hospital, said a top executive. Bioheart, which is backed by the Middle


Stem cells therapy 'helps damaged heart'

US-based Bioheart has announced a medical breakthrough in cardiovascular therapy by using stem cells of fat tissues of patient’s own body. Regeneration of a damaged heart is possible through stem cells derived from a patient’s own fat tis


Jordan centre pioneers heart research

The Philadelphia Biological and Medical Technology Product Development Centre in Amman, Jordan has made a major medical breakthrough in the treatment of potentially life-threatening, heart-related aliments. According to Peggy Farley, manag

 1 2 3 4 5 >  Last ›

calendarCalendar of Events